Inovio's COVID-19 vaccine INO-4800 selected for WHO Solidarity Trial Vaccines Phase 3

INOVIO PHARMACEUTICALS, INC.

WHO confirmed Oct 26, 2021 that INO-4800 is one of two vaccines in large international Phase 3 Solidarity Trial.
Selected by independent advisory group from ~20 candidate vaccines; two more vaccines may enter later.
Trial recruiting volunteers at over 40 sites across Colombia, Mali, and the Philippines.
Inovio also conducting separate global Phase 3 INNOVATE trial with partner Advaccine.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.